Evidence map›Paper›PMID 35497295›Full record

ArticleRSC advances2021

A highly selective pyridoxal-based chemosensor for the detection of Zn(ii) and application in live-cell imaging; X-ray crystallography of pyridoxal-TRIS Schiff-base Zn(ii) and Cu(ii) complexes.

Anwar Hussain, Kadarkaraisamy Mariappan, Dawson C Cork, Luke D Lewandowski, Prem K Shrestha, Samiksha Giri, Xuejun Wang, Andrew G Sykes

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 25 citations in OpenAlex.

  1. Experimental and DFT Investigation of a Vitamin BSensors (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anwar HussainContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.ORCID https://orcid.org/0000-0003-0821-0611
Kadarkaraisamy MariappanContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.
Dawson C CorkContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.
Luke D LewandowskiContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.
Prem K ShresthaContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.
Samiksha GiriBasic Biomedical Science, University of South Dakota, School of Medicine Vermillion SD 57069 USA.
Xuejun WangBasic Biomedical Science, University of South Dakota, School of Medicine Vermillion SD 57069 USA.
Andrew G SykesContribution from the Department of Chemistry, University of South Dakota Vermillion SD 57069 USA Andrew.Sykes@usd.edu.ORCID https://orcid.org/0000-0001-6751-969X
University of South Dakota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a simple, one-step reaction, we have synthesized a pyridoxal-based chemosensor by reacting tris(hydroxymethyl)aminomethane (TRIS) together with pyridoxal hydrochloride to yield a Schiff-base ligand that is highly selective for the detection of Zn(ii) ion. Both the ligand and the Zn(ii) complex have been characterized by

Identifiers

PMID35497295
PMCPMC9042327
OpenAlexW3210622678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.